Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on: February 05,2025

Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on:February 05,2025

Spinal fluid biomarkers detect neurodegeneration, Alzheimer's disease in living patients

by Perelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAlzheimer's disease and related diseases can still only be confirmed in deceased patients&#39

Updated on: June 18,2024

Spinal fluid biomarkers detect neurodegeneration, Alzheimer's disease in living patients

by Perelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAlzheimer's disease and related diseases can still only be confirmed in deceased patients&#39

Updated on:June 18,2024

Dementia prevention strategies could save £1.9 billion annually

by University College LondonCredit: CC0 Public DomainPrograms to reduce dementia risk by targeting smoking, high blood pressure and hearing loss are likely to be cost-effective and cost saving by

Updated on: May 11,2024

Dementia prevention strategies could save £1.9 billion annually

by University College LondonCredit: CC0 Public DomainPrograms to reduce dementia risk by targeting smoking, high blood pressure and hearing loss are likely to be cost-effective and cost saving by

Updated on:May 11,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Primate study sheds light on a neural mechanism that separates signal from noise in the brain

byUniversity of TokyoMesoscale functional imaging revealed patchy spatial patterns of spontaneous activity throughout the marmoset neocortex. Credit:Nature Communications(2024). DOI:

Updated on: December 17,2024

Primate study sheds light on a neural mechanism that separates signal from noise in the brain

byUniversity of TokyoMesoscale functional imaging revealed patchy spatial patterns of spontaneous activity throughout the marmoset neocortex. Credit:Nature Communications(2024). DOI:

Updated on:December 17,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on: February 26,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on:February 26,2024

Experimental Alzheimer's drug improves memory in mice

by Sarah C.p. Williams,University of California, Los AngelesCredit: CC0 Public DomainAn experimental drug known as A03, which was previously developed to treat depression, increases the levels o

Updated on: March 09,2024

Experimental Alzheimer's drug improves memory in mice

by Sarah C.p. Williams,University of California, Los AngelesCredit: CC0 Public DomainAn experimental drug known as A03, which was previously developed to treat depression, increases the levels o

Updated on:March 09,2024

Brain signals linked to sweet taste preference discovered

Updated on: March 17,2025

Brain signals linked to sweet taste preference discovered

Updated on:March 17,2025

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on: December 11,2024

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on:December 11,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on: March 30,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on:March 30,2024